CareDx Statistics
Total Valuation
CareDx has a market cap or net worth of $772.86 million. The enterprise value is $599.85 million.
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CareDx has 53.23 million shares outstanding. The number of shares has increased by 10.85% in one year.
| Current Share Class | 53.23M |
| Shares Outstanding | 53.23M |
| Shares Change (YoY) | +10.85% |
| Shares Change (QoQ) | -1.05% |
| Owned by Insiders (%) | 2.64% |
| Owned by Institutions (%) | 99.92% |
| Float | 51.82M |
Valuation Ratios
The trailing PE ratio is 12.64 and the forward PE ratio is 18.62.
| PE Ratio | 12.64 |
| Forward PE | 18.62 |
| PS Ratio | 2.19 |
| Forward PS | 1.85 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 3.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 8.92 |
| EV / Sales | 1.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.03 |
| Quick Ratio | 2.44 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.01% and return on invested capital (ROIC) is -6.37%.
| Return on Equity (ROE) | 23.01% |
| Return on Assets (ROA) | -4.45% |
| Return on Invested Capital (ROIC) | -6.37% |
| Return on Capital Employed (ROCE) | -9.72% |
| Revenue Per Employee | $550,766 |
| Profits Per Employee | $103,418 |
| Employee Count | 650 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 4.87 |
Taxes
In the past 12 months, CareDx has paid $97,000 in taxes.
| Income Tax | 97,000 |
| Effective Tax Rate | 0.14% |
Stock Price Statistics
The stock price has decreased by -35.87% in the last 52 weeks. The beta is 2.56, so CareDx's price volatility has been higher than the market average.
| Beta (5Y) | 2.56 |
| 52-Week Price Change | -35.87% |
| 50-Day Moving Average | 14.37 |
| 200-Day Moving Average | 17.12 |
| Relative Strength Index (RSI) | 48.76 |
| Average Volume (20 Days) | 1,020,339 |
Short Selling Information
The latest short interest is 6.05 million, so 11.36% of the outstanding shares have been sold short.
| Short Interest | 6.05M |
| Short Previous Month | 6.24M |
| Short % of Shares Out | 11.36% |
| Short % of Float | 11.67% |
| Short Ratio (days to cover) | 4.72 |
Income Statement
In the last 12 months, CareDx had revenue of $358.00 million and earned $67.22 million in profits. Earnings per share was $1.15.
| Revenue | 358.00M |
| Gross Profit | 242.15M |
| Operating Income | -32.40M |
| Pretax Income | 67.32M |
| Net Income | 67.22M |
| EBITDA | -17.87M |
| EBIT | -32.40M |
| Earnings Per Share (EPS) | $1.15 |
Full Income StatementBalance Sheet
The company has $194.22 million in cash and $21.21 million in debt, giving a net cash position of $173.01 million or $3.25 per share.
| Cash & Cash Equivalents | 194.22M |
| Total Debt | 21.21M |
| Net Cash | 173.01M |
| Net Cash Per Share | $3.25 |
| Equity (Book Value) | 311.14M |
| Book Value Per Share | 5.93 |
| Working Capital | 201.24M |
Full Balance SheetMargins
Gross margin is 67.64%, with operating and profit margins of -9.05% and 18.78%.
| Gross Margin | 67.64% |
| Operating Margin | -9.05% |
| Pretax Margin | 18.80% |
| Profit Margin | 18.78% |
| EBITDA Margin | -4.99% |
| EBIT Margin | -9.05% |
| FCF Margin | n/a |
Dividends & Yields
CareDx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.85% |
| Shareholder Yield | -10.85% |
| Earnings Yield | 8.70% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CareDx is $26.86, which is 84.99% higher than the current price. The consensus rating is "Buy".
| Price Target | $26.86 |
| Price Target Difference | 84.99% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
